Richard D Wainford Selected Research

Salts

6/2023	2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action.
1/2023	Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension.
1/2022	Central Gαi2 Protein Mediated Neuro-Hormonal Control of Blood Pressure and Salt Sensitivity.
1/2021	Neuroanatomical characterization of Gαi2-expressing neurons in the hypothalamic paraventricular nucleus of male and female Sprague-Dawley rats.
11/2020	Sympathetic Regulation of the NCC (Sodium Chloride Cotransporter) in Dahl Salt-Sensitive Hypertension.
1/2020	Hypothalamic Paraventricular Nucleus Gαi2 (Guanine Nucleotide-Binding Protein Alpha Inhibiting Activity Polypeptide 2) Protein-Mediated Neural Control of the Kidney and the Salt Sensitivity of Blood Pressure.
12/2019	Inhibition of microglial activation in rats attenuates paraventricular nucleus inflammation in Gαi2 protein-dependent, salt-sensitive hypertension.
12/2019	Sympathetic regulation of NCC in norepinephrine-evoked salt-sensitive hypertension in Sprague-Dawley rats.
1/2019	Role of the afferent renal nerves in sodium homeostasis and blood pressure regulation in rats.
1/2018	GNAI2 polymorphic variance associates with salt sensitivity of blood pressure in the Genetic Epidemiology Network of Salt Sensitivity study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Wainford Research Topics

Disease

22	Hypertension (High Blood Pressure) 01/2024 - 02/2013
3	Obesity 01/2023 - 05/2015
2	Heart Failure 01/2022 - 03/2012
2	COVID-19 01/2022 - 01/2021
2	Chronic Disease (Chronic Diseases) 11/2019 - 03/2012
1	Venous Thromboembolism 01/2022
1	Myocardial Infarction 01/2022
1	Essential Hypertension 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Inflammation (Inflammations) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Chronic Renal Insufficiency 01/2016
1	Hypoxia (Hypoxemia) 05/2015
1	Weight Gain 01/2015
1	Cachexia 03/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2012

Drug/Important Bio-Agent (IBA)

18	SaltsIBA 06/2023 - 02/2013
7	Dietary SodiumIBA 06/2023 - 01/2015
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
7	SodiumIBA 01/2021 - 02/2013
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2020 - 02/2013
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2015
2	Sodium Chloride SymportersIBA 11/2020 - 01/2016
2	OligodeoxyribonucleotidesIBA 01/2020 - 02/2013
2	Messenger RNA (mRNA)IBA 12/2019 - 12/2019
2	Antihypertensive Agents (Antihypertensives)IBA 04/2019 - 01/2015
2	Angiotensin IIIBA 05/2015 - 03/2012
1	Gi2 GTP-Binding Protein alpha Subunit (GTP Binding Protein alpha Subunit, Gi2)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Member 3 Solute Carrier Family 12IBA 12/2019
1	Minocycline (Cyclops)FDA LinkGeneric 12/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2019
1	CytokinesIBA 12/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	AldosteroneIBA 06/2015
1	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2015
1	Acetates (Acetic Acid Esters)FDA Link 01/2015
1	ReninIBA 02/2013
1	Muscle Proteins (Muscle Protein)IBA 03/2012

Therapy/Procedure

2	Denervation 01/2024 - 09/2023
2	Therapeutics 01/2022 - 01/2021
1	Critical Care (Surgical Intensive Care) 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022